Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Active-treatment Study of the Efficacy of Ziv-aflibercept in Patients With Neovascular Age-Related Macular Degeneration

NCT03423823 is registered in ClinicalTrials.gov with Kapil Kapoor as lead sponsor.

NCT NCT03423823
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03423823 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Active-treatment Study of the Efficacy of Ziv-aflibercept in Patients With Neovascular Age-Related Macular Degeneration
Lead sponsor
Kapil Kapoor
Phase
Phase 2
Overall status
Completed
Start date
July 7, 2017
Completion date
June 26, 2020
Enrollment
62 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

wet age-related macular degeneration, wet macular degeneration